期刊文献+

盐酸尼非卡兰的合成 被引量:1

Synthesis of Nifekalant Hydrochloride
在线阅读 下载PDF
导出
摘要 以N ,N′ 二甲基脲为原料 ,经氰乙酸环合、乙醇胺脱氨、二氯亚砜氯化 3步反应合成了关键中间体 6 (2 氯乙基 )胺基 1,3 二甲基 嘧啶二酮 (7)。 7再与N (2 羟乙基 ) 3 (4 硝基苯基 )丙胺反应得抗心律失常药盐酸尼非卡兰 ,总收率为 4 8.0 % (以N ,N′ 二甲基脲计 ) 。 Chloroethyl)amino-1,3-dimethylpyrimidinedione(7), as a key intermediate, was prepared in three steps by condensation of N,N′-dimethylurea successively with cyanoacetic acid and ethanolamine, and then chlorination with thionyl chloride. Nifekalant hydrochloride, an antiarrhythmic drug, was synthesized by amination of 7 with N-(2-hydroxylethyl)-3-(4-nitrophenyl)propylamine, the total yield could reach up to 48.0%. The structure of nifekalant hydrochloride was confirmed by NMR and MS.
出处 《合成化学》 CAS CSCD 2004年第4期388-390,J004,共4页 Chinese Journal of Synthetic Chemistry
关键词 抗心律失常药 尼非卡兰 合成 antiarrhythmic drug nifekalant synthesis
  • 相关文献

参考文献5

  • 1Sekita G,Sawaki D,Otani Y,et al. Pretreatments with a Novel Pure Potassium Channel Blocker, Nifekalant, Were Effective in the Electrical Atrial Defibrillation[J].Cardiovascular Drug and Therapy,2002,16(6):551-552.
  • 2Thomas J,Colatsky M,Thomas M,et al. Potassium Channel Blockers as Antiarrhythmic Drugs[J].Drug Dev Res,1994,33(3):235-249.
  • 3Katakami T,Tatsuro K,Yokoyama T,et al. Pyrimidinedione Compounds Method of Producing the Same and Antiarrythmic Agents Containing the Same[P].US 5 008 267,1991.
  • 4Wolfgang P,Kurt K,Wolfgang S. Hypotensive (4-arylpiperazinylalkylamino)uracil Derivatives[P].Ger Offen 1 942 405,1969.
  • 5Chen J,Komori S,Li B,et al. Ik Independent Class Ⅲ Actions of MS-551 Compared with Sematilide and Dofetilide During Reperfustion in Anaesthetized Rats[J].Journal of Pharmacology,1996,119:937-942.

同被引文献5

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部